The U.S. Food and Drug Administration said on Wednesday that it has approved Bayer's drug for patients with a form of lung ...

Targeted therapies, guided by molecular testing, offer significant benefits, including fewer side effects and personalization ...

Just a few months after Boehringer Ingelheim broke into the oncology space with the first drug that can target a rare tumor ...

The FDA announced accelerated approval of sevabertinib (Hyrnuo) for HER2-positive non-small cell lung cancer (NSCLC).

The Food and Drug Administration (FDA) granted traditional approval to Imdelltra (tarlatamab-dlle) for adult patients with ...

Joanne Cure, 78, survived stage 4 lung cancer after being given two years to live, crediting her faith, determination, and ...

Living with lung cancer often means spending more time in waiting rooms than in the moments that matter. But that could ...

Nuvalent filed a new drug application for an experimental non-small cell lung cancer treatment with the Food and Drug Administration.

Lung cancer is the leading cause of cancer-related deaths in the United States. As we start Lung Cancer Awareness Month, a new report shows where we stand on fighting against the disease, including ...

MONTGOMERY, Ala. ( WSFA) - November is Lung Cancer Awareness Month putting a national spotlight on early detection and better ...

New artificial intelligence technology is helping diagnose the U.S.’s most deadly cancer sooner, greatly improving the ...

The U.S. Food and Drug Administration on Wednesday said it has approved Bayer's drug for patients with a type of lung cancer ...